Welcome to our dedicated page for Petmed Express news (Ticker: PETS), a resource for investors and traders seeking the latest updates and insights on Petmed Express stock.
PetMed Express Inc (PETS), America's largest online pet pharmacy, provides this centralized hub for official corporate communications and market-moving developments. Access verified press releases, SEC filings, and strategic announcements from the nation's leading direct-to-consumer pet medication provider.
Investors and industry observers will find comprehensive coverage of financial results, regulatory updates, product innovations, and partnership agreements. Our curated news feed tracks material events impacting PETS' position in the $100B pet healthcare market, including prescription medication approvals and e-commerce platform enhancements.
Key updates include quarterly earnings disclosures, FDA compliance announcements, and distribution network expansions. All content is sourced directly from company filings and official statements to ensure regulatory compliance and factual accuracy.
Bookmark this page for real-time access to PETS' corporate communications, including 8-K filings detailing material events and 10-K annual reports. Check regularly for updates on the company's mission to deliver affordable pet healthcare through its innovative online pharmacy model.
PetMed Express (NASDAQ: PETS) has appointed Matt Hulett as its new CEO and President, effective immediately. Hulett, a technology executive with over 30 years of experience, previously worked at Rosetta Stone and Expedia, focusing on digital consumer growth. Board Chairman Dr. Gian Fulgoni highlighted Hulett's expertise in technology and digital transformation, anticipating positive impacts on PetMeds' growth in the expanding digital pet pharmacy market. Hulett expressed excitement about the potential for PetMeds to capitalize on the $100 billion pet market, aiming for strong growth.
PetMed Express, Inc. (NASDAQ: PETS) announced the election of Jodi Watson and Peter Cobb as independent directors to its Board. Watson brings over 20 years of experience in digital transformation and leadership from companies like Petco and Williams-Sonoma. Cobb co-founded eBags.com and has expertise in digital retail and customer loyalty programs. Both will serve on the Audit, Compensation, and Corporate Governance Committees. The Board Chairman expressed confidence in their ability to contribute significantly as the company undergoes transformation.
PetMed Express (PETS) reported Q1 FY 2022 results with net sales of $79.3 million, down from $96.2 million a year ago. Net income was $4.4 million ($0.22/share), a decline from $7.8 million ($0.39/share) a year earlier. One-time charges totaled $717,000 due to the CEO's separation. Increased veterinary visits during the pandemic impacted sales, but future reorder sales are expected to be stronger. The company holds over $111 million in cash with no debt and declared a quarterly dividend of $0.30 per share, payable August 13, 2021.
PetMed Express (NASDAQ: PETS) will announce its financial results for the quarter ended June 30, 2021, on July 26, 2021, at 8:00 A.M. Eastern Time.
A conference call to discuss the results will follow at 8:30 A.M. ET, and is accessible to the public by dialing (888) 455-1758 or (203) 827-7025. A replay of the call will be available from July 26 at 10:00 A.M. until August 9, 2021.
Founded in 1996, PetMed Express delivers prescription and non-prescription medications for pets directly to consumers.
PetMed Express reported strong fiscal 2021 results, showing an 8.8% increase in net sales to $309.2 million and a 18.4% increase in net income to $30.6 million. Despite fourth-quarter challenges, with a 3.5% decrease in net sales to $71.7 million, the overall year reflected a successful pivot to e-commerce driven by COVID-19. The company acquired 443,000 new customers and improved average order size. An increased quarterly dividend of $0.30 per share was declared, reflecting ongoing confidence in future growth.
PetMed Express (PETS) will announce its financial results for the fiscal year ending March 31, 2021, on May 3, 2021, at 8:00 A.M. ET. CEO Menderes Akdag will host a conference call at 8:30 A.M. ET to discuss the results. The call is accessible to the public by dialing (888) 455-1758 or (203) 827-7025. A replay of the call will be available until May 17, 2021. Founded in 1996, PetMed Express is a leading pet pharmacy in the U.S. offering medications and health products for pets through its toll-free number and website.
PetMed Express, Inc. (NASDAQ: PETS) reported a 10% increase in quarterly net sales, reaching $65.9 million for the quarter ended December 31, 2020, compared to $59.9 million in the same quarter of 2019. Diluted EPS rose to $0.38 from $0.34. Year-to-date sales were $237.5 million, up 13.2%. Reorder sales climbed 11.9% to $60.2 million for the quarter. A quarterly dividend of $0.28 per share was declared, payable on February 12, 2021. The company continues to focus on enhancing customer experience and expanding its digital offerings.
PetMed Express will release its Q3 financial results for the period ending December 31, 2020, on January 19, 2021, at 8:00 A.M. Eastern Time. Following this, CEO Menderes Akdag will host a conference call at 8:30 A.M. Eastern Time to discuss the results. Participants can join the call by dialing (888) 455-1758 or (203) 827-7025 and must provide the passcode PETMEDS. For those unable to attend live, a replay will be available until February 2, 2021.
PetMed Express reported a strong performance for Q2 2020 with net sales reaching $75.4 million, up 7.9% from $69.9 million in Q2 2019. The net income rose 26.2% to $8.4 million or $0.42 per diluted share. Reorder sales also saw a significant increase of 9.6% to $67.8 million. With gross margins improving from 27.8% to 30.5%, the company is set to enhance its digital presence by redesigning its website and mobile app. A quarterly dividend of $0.28 per share was declared, payable on November 20, 2020.
PetMed Express (NASDAQ: PETS) is scheduled to announce its financial results for Q2 2020 on October 26, 2020, at 8:00 A.M. ET. CEO Menderes Akdag will host a conference call at 8:30 A.M. ET to discuss these results. The call is public and can be accessed at (888) 455-1758 with the passcode PETMEDS. A replay will be available from 10:00 A.M. ET on the same day until November 9, 2020. PetMed Express is recognized as America’s Largest and Most Trusted Pet Pharmacy, providing prescription and non-prescription pet medications directly to consumers.
FAQ
What is the current stock price of Petmed Express (PETS)?
What is the market cap of Petmed Express (PETS)?
